{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL) (IND# 134379)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-3-study-of-131i-metaiodobenzylguanidine-131i-mibg-or-crizotinib-added-to-intensive-therapy-for-children-with-newly-diagnosed-high-risk-neuroblastoma-nbl-ind-134379\/#breadcrumbitem"}]}